Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Bad Is Biogen's Latest Bad News?

TheMotleyFool

0 0

How Bad Is Biogen's Latest Bad News?Photo, wide shot, wide-angle lens, Laundry service, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/7d06f1e2-46d1-4cac-90e0-6cc2313e43fe.png

Biogen (NASDAQ: BIIB) received fantastic news in early June with the U.S. Food and Drug Administration (FDA) approved Aduhelm in treating Alzheimer's disease. However, the drugmaker has reported some not-so-great news in recent weeks. In this Motley Fool Live video recorded on June 16, Motley Fool contributors Keith Speights and Brian Orelli discuss just how bad Biogen's latest bad news is for the company.

Source Fool.com

Like: 0

BIIB

Share